Stockreport

Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial

Novavax, Inc.  (NVAX) 
Last novavax, inc. earnings: 3/11 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novavax.com/investor-relations
PDF Trial also achieves statistical significance in key secondary endpointsNovavax to submit a U.S. BLA under FDA’s accelerated approval pathwayCompany to host investor conf [Read more]